GSK Settles Zantac Cancer Claims
This is a UK news story, published by BBC, that relates primarily to GSK news.
UK news
For more UK news, you can click here:
more UK newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsBBC news
For more news from BBC, you can click here:
more news from BBCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
heartburn drug Zantac. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest pharmaceutical giant GSK news, Zantac news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Zantac cancerBBC
•Pharma giant GSK to pay $2.2 to settle Zantac lawsuits
77% Informative
UK firm GSK to pay $ 2.2bn over Zantac cancer claims.
Firm reached agreements with 10 law firms who represent around 80,000 claimants.
GSK will also pay $ 70 m to resolve a whistleblower complaint by a lab that alleged the drugmaker defrauded the US government by concealing cancer risks.
VR Score
79
Informative language
77
Neutral language
66
Article tone
formal
Language
English
Language complexity
42
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links